Fujian Wanchen Biotechnology Group Co., Ltd. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a growth in Operating Profit of 228.9%, the company declared Outstanding results in Mar 25

The company has declared positive results for the last 4 consecutive quarters
OPERATING CASH FLOW(Y) Highest at CNY 1,286.88 MM
NET SALES(Q) At CNY 10,793.17 MM has Grown at 123.95%
PRE-TAX PROFIT(Q) At CNY 523.61 MM has Grown at 362.85%

With ROE of 81.98%, it has a expensive valuation with a 16.17 Price to Book Value

Consistent Returns over the last 3 years

Mojo Parameters

Stock DNA

Industry

Other Agricultural Products

Market cap

CNY 26,234 Million (Large Cap)

P/E

20.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.22

Return on Equity

81.98%

Price to Book

16.17

Revenue and Profits:

Net Sales:

11,735 Million

(Quarterly Results - Jun 2025)

Net Profit:

482 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

109.71%

6 Months

125.11%

1 Year

677.45%

2 Years

320.68%

3 Years

1325.02%

4 Years

880.52%

5 Years

0.0%

Fujian Wanchen Biotechnology Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

233.73%

EBIT Growth (5y)

293.10%

EBIT to Interest (avg)

9.86

Debt to EBITDA (avg)

0.40

Net Debt to Equity (avg)

-1.12

Sales to Capital Employed (avg)

8.16

Tax Ratio

36.09%

Dividend Payout Ratio

35.00%

Pledged Shares

Institutional Holding

ROCE (avg)

8.42%

ROE (avg)

20.88%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

16.17

EV to EBIT

12.84

EV to EBITDA

11.12

EV to Capital Employed

-69.30

EV to Sales

0.55

PEG Ratio

0.02

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

81.98%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 93.22% vs 318.71% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 545.65% vs 171.90% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,734.90",
          "val2": "6,073.40",
          "chgp": "93.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "728.70",
          "val2": "235.10",
          "chgp": "209.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.50",
          "val2": "11.70",
          "chgp": "6.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "482.30",
          "val2": "74.70",
          "chgp": "545.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "55.70%",
          "val2": "27.20%",
          "chgp": "2.85%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 247.96% vs 1,598.32% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 513.22% vs -451.81% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32,265.40",
          "val2": "9,272.80",
          "chgp": "247.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,263.80",
          "val2": "140.80",
          "chgp": "797.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "53.30",
          "val2": "31.00",
          "chgp": "71.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.80",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "603.30",
          "val2": "-146.00",
          "chgp": "513.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.50%",
          "val2": "-5.50%",
          "chgp": "3.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

11,734.90

6,073.40

93.22%

Operating Profit (PBDIT) excl Other Income

728.70

235.10

209.95%

Interest

12.50

11.70

6.84%

Exceptional Items

0.00

Consolidate Net Profit

482.30

74.70

545.65%

Operating Profit Margin (Excl OI)

55.70%

27.20%

2.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 93.22% vs 318.71% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 545.65% vs 171.90% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

32,265.40

9,272.80

247.96%

Operating Profit (PBDIT) excl Other Income

1,263.80

140.80

797.59%

Interest

53.30

31.00

71.94%

Exceptional Items

0.00

-0.80

100.00%

Consolidate Net Profit

603.30

-146.00

513.22%

Operating Profit Margin (Excl OI)

30.50%

-5.50%

3.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 247.96% vs 1,598.32% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 513.22% vs -451.81% in Dec 2023

All Annual Results

Company CV

About Fujian Wanchen Biotechnology Group Co., Ltd.

Fujian Wanchen Biotechnology Group Co., Ltd.

Other Agricultural Products

No Details Available.

Company Coordinates

No Company Details Available